Dr. Jacques,
You raise some very interesting questions. The answers to those questions are not entirely clear cut. I would second Elaine's answer to your original question and will try to add my perspective as well.
With respect to cataracts, I would point you to the UHMS Indications Manual 15th ed. Pages 365 and 366 discuss ocular complication including myopia, cataracts, and retinopathy of prematurity. In essence, at the number of treatment typically used in clinical hyperbaric medicine, new cataracts should not form. It is possible for pre-existing cataracts to worsen, and patients should be told about this possible HBO side effect.
With respect to Glaucoma, multiple studies from the diving literature and HBO literature indicate that intraocular pressure is reduced with increased ambient pressure (HBO chamber or diving). A meta-analysis from 2024 (https://doi.org/10.3389/fmed.2024.1365259) agrees with this.
With respect to macular degeneration and those on anti-VEGF meds, an very interesting Ukranian study from 2022 (https://doi.org/10.3389/fmed.2024.1365259) compared outcomes in patients with diabetic macular edema who were treated with Eylea or Eylea and adjunctive HBO. The group treated with Eylea and adjunctive HBO showed greater improvements in in visual acuity and and more profound decrease in retinal thickness than the group treated with Eylea alone.
Finally, with respect to taking prophylactic anti-oxidants with HBO. Some HBO practioners will give patients Vitamin E as a anti-oxidative measure. Some people believe this MAY help decrease the risk of oxygen toxicity seizures. One expert opinion review (https://www.sciencedirect.com/science/article/pii/S188842961730050X) indicated that anti-oxidants should be considered in at risk patients.
I have also included a wonderful review article from 2024 that address many of the points you raise (https://www.mdpi.com/2077-0383/13/1/29). I hope this helps to answer some of your questions.
Mike White